Innovation and Product Development news (page 11)

• 

  6 May 2026

  Eli Lilly commits $4.5B to Indiana manufacturing, opens first genetic‑medicine facility

  Buildout now totals $21B in Indiana since 2020; upgrades at Lebanon API to produce Foundayo, Zepbound/Mounjaro and retatrutide; project to scale API capacity and boost regional jobs and GDP.
• 

  6 May 2026

  Topsoe and BioVeritas partner on second‑generation renewable fuels

  Deal enables conversion of second-gen feedstocks (woody biomass, corn stover, straw, wastes) into KEYTones for processing with HydroFlex, allowing scalable renewable fuels and SAF in existing plants.
• 

  6 May 2026

  ORLEN partners with AWS for cloud-based digital transformation

  Migrate IT to cloud and adopt cloud-native apps to improve efficiency, scalability and security; use AI/ML, analytics and ISV solutions; multi-cloud strategy and staff upskilling.
• 

  6 May 2026

  Carbon Neutral Fuels' Project Starling completes FEL3A, advancing UK eSAF deployment

  FEL3A completed for UK eSAF project: integrated design and 3D model, Class 3 cost estimate. Targets 25,000 tpa by 2031 with ~95% lifecycle GHG reduction; DAC integrated.
• 

  6 May 2026

  Nouryon launches Perkadox PM-60ST-GR to restore recycled polypropylene performance

  Organic peroxide added in extrusion restores recycled PP chains, raising melt viscosity and resistance (up to 10×) to allow more recycled content in packaging, auto and consumer goods
• 

  6 May 2026

  Aramco and solutions by stc to deploy next-generation Upstream supercomputer

  Next-gen supercomputer will boost Upstream compute—7× capacity—for seismic imaging and reservoir simulation, improving hydrocarbon discovery, recovery and field life; delivery 2027

• 

  6 May 2026

  CATL and HyperStrong sign 60GWh sodium‑ion energy‑storage supply pact

  Three-year sodium‑ion energy-storage deal to industrialize mass production: higher energy density, manufacturing fixes for consistent output, improved safety, and Li‑ion form‑factor compatibility
• 

  5 May 2026

  SABIC launches ULTEM SU3102P oligomer for tougher, lighter aerospace composites

  Reactive PEI oligomer increases thermoset composite toughness/stiffness up to 140% vs rPES, permits loadings to 50% with low viscosity, and can cut prepreg cycle time/energy use by ~30%.
• 

  5 May 2026

  Iberdrola upgrades Valdecañas pumped storage, adding 355 MW and 210 GWh

  Valdecañas pumped-storage started pumping, linking Alcántara and Valdecañas reservoirs into a gigabattery with a hybrid battery, aiding renewables integration, grid stability and flood control
• 

  5 May 2026

  Johnson & Johnson: TREMFYA (guselkumab), first IL‑23 inhibitor to show efficacy in perianal fistulizing Crohn’s disease

  Phase 3 FUZION: Week‑24 combined fistula remission 28.3% (100 mg q8w) and 27.0% (200 mg q4w) vs 10.3% placebo; safety profile consistent; CHARGE head‑to‑head trial initiated.
• 

  5 May 2026

  Heidelberg Materials commissions 1.25 Mt/yr Airvault kiln line to improve efficiency and reduce CO2

  1.25 Mt/yr dry kiln replaces old lines; enables ~90% alternative fuels, reduces electricity ~10% and CO2 ~30%; €350M upgrade includes calcined-clay use and CCUS (1 Mt/yr).
• 

  5 May 2026

  Merck acquires Terns Pharmaceuticals

  Adds TERN‑701, an oral allosteric BCR::ABL1 TKI with FDA Breakthrough for certain CML patients. Bought via $53/share tender and merger; ~$5.8B R&D charge; Terns now delisted and private.
• 

  5 May 2026

  LANXESS Lewatit MDS TP 108 Removes >99.9% PFAS at Chemours

  Selective monodisperse ion-exchange resin removed >99.9% of fluorinated organics in wastewater, targeting short-chain PFAS via a 3-stage RO, carbon, resin cascade; spent resin incinerated.
• 

  5 May 2026

  Lilly's Omvoh first IL-23p19 to show durable four-year disease clearance in ulcerative colitis

  Mirikizumab showed durable disease clearance in moderate-severe ulcerative colitis: 63.5% who cleared at 1 year sustained it at 4 years; stringent remission 61.3%; safety profile consistent.
• 

  4 May 2026

  Johnson & Johnson: IMPACT pilot finds planned Impella 5.5 safe and feasible in high‑risk non‑shock cardiac surgery patients

  IMPACT pilot (N=100) found planned pre‑CPB Impella 5.5 in non‑shock, high‑risk cardiac surgery (LVEF≤35%) was safe and feasible with low device‑related events; investigational.
• 

  4 May 2026

  BASF Engineering Plastics Certified to EN 45545 Railway Standard

  Ultramid and Ultradur grades certified to EN 45545 for railway E&E. Halogen‑free flame retardants (intumescent, Mg(OH)2), color‑independent approval and defined thicknesses for design freedom.
• 

  4 May 2026

  Johnson & Johnson: CAPLYTA tops adjunctive MDD antipsychotics in network meta-analysis

  Network meta-analysis of 10 trials found an adjunctive atypical antipsychotic superior on MADRS change, response, remission and CGI‑S, with no significant weight gain and favorable tolerability.
• 

  4 May 2026

  Stahl launches Repura barrier coatings for paper packaging

  Repura™ coatings deliver high oil, water/MVTR and oxygen barriers for paper & board and flexible packaging; repulpable, food-contact capable, customizable—shown at Interpack 2026
• 

  4 May 2026

  Siemens expands digital portfolio for water & waste management

  Real-time water-quality monitoring, SIWA Treatment Optimizer (digital twin) cutting energy/emissions up to 25%, soft sensors, integrated control center and expanded waste-management automation
• 

  4 May 2026

  UPM and BASF advance recyclable fiber-based packaging

  Barrier papers paired with Joncryl HPB coatings enable high-performance, recyclable fiber-based packaging; samples to be shown at interpack 2026, supporting design-for-recycling rules.
• 

  1 May 2026

  Petrobras starts Búzios 8 (P-79) production

  Brought online three months early, FPSO adds 180,000 bpd and 7.2M m³/d compression, raising field capacity to ~1.33M bpd; 14 wells planned and up to 3M m³/d gas export.
• 

  1 May 2026

  Novo Nordisk launches Ozempic pill — FDA‑approved oral semaglutide for adults with type 2 diabetes

  Tablets (1.5, 4, 9 mg) debut in US May 4. Reformulated from Rybelsus, available at 70,000+ pharmacies; insurance from $25; self-pay $149/199/299/month. Approved to reduce cardiovascular events
• 

  30 April 2026

  Messer 2025 sustainability report — 2% GHG reduction

  Year‑on‑year 2% reduction in market‑based GHGs from operations; renewable electricity and solar installs; ZeCarb carbon services; independent limited assurance for materiality and select KPIs.
• 

  30 April 2026

  Reliance Retail acquires Anomaly haircare (Priyanka Chopra Jonas)

  Full ownership of Anomaly trademarks, brand assets and digital properties to scale the clean, vegan haircare line through omnichannel retail and digital platform Tira.
• 

  30 April 2026

  Sinopec launches Fenghuo industrial AI agent

  Introduces 'Fenghuo' industrial AI agent: a production-capable digital colleague that analyzes data, runs engineering simulations, invokes toolchains, and executes long multi-step tasks autonomously.
• 

  30 April 2026

  Evonik expands Americas fast‑cure epoxy range with Ancamine 2868 and 2844

  New epoxy hardeners enable rapid thin-film cure and fast property build at low temps/high humidity, boosting formulation flexibility and corrosion/carbamation resistance for protective coatings
• 

  30 April 2026

  Petrobras posts 1Q26 own production record of 3.23 MMboed

  Ramp-up of multiple FPSOs and 10 new wells drove production gains (3.7% QoQ, 16.1% YoY); operated production 4.65 MMboed. Refining utilization, S10 diesel output and logistics records; LPG imports fell.
• 

  30 April 2026

  Symrise expands Food & Beverage capabilities in Barcelona

  Upgraded site adds powdered production and large-scale mixer, modern application and quality labs for faster prototyping, smoother scale-up, local technical support, and solar/water reuse.
• 

  30 April 2026

  Umicore Q1 momentum points to ~€1bn adjusted EBITDA in 2026

  Strong Q1: Catalysis and Recycling strong; Specialty led by cobalt; CAM volumes modest, take‑or‑pay compensation; anode JV in place; capex up; leverage <2x
• 

  30 April 2026

  Borouge Q1 2026: $156M Net Profit on Operational Resilience

  Q1 revenue $1.2B; production 1.21Mt (98% capacity), sales 1.09Mt. 61% of March output rerouted via alternative logistics. Prices rose 62% in March. H2 2025 dividend $658M; merger forms global polyolefins platform.